IgM response to a human Pneumocystis carinii surface antigen in HIV-infected patients with pulmonary symptoms.

Bettina Lundgren, J A Kovacs, Lars Reinhardt Mathiesen, Jens Ole Nielsen, Jens Dilling Lundgren

14 Citations (Scopus)

Abstract

We have developed an ELISA to detect IgM antibodies to a major human Pneumocystis carinii surface antigen (gp95), and investigated the IgM response in 128 HIV-infected patients who underwent bronchoscopy for evaluation of pulmonary symptoms. Only 5 (4%) patients had IgM antibodies to P. carinii gp95. Four of the 5 patients with IgM antibodies also had IgG antibodies to gp95 and microbiologically proven P. carinii pneumonia (PCP). In 76/128 patients for whom serial samples were available, changes in antibody response were determined. In 3 patients we demonstrated an increase in IgM antibody response to gp95. These patients also showed an increase in IgG antibodies to gp95 and had microbiologically proven PCP. Prior to the development of the IgM response, IgG antibodies to gp95 were detectable in all 3 patients. Thus, HIV-infected patients with PCP seldom produce IgM antibodies to the major human P. carinii surface antigen. The increase in IgM response during the course of PCP observed in 3 patients suggests either reinfection with a new strain, or antigenic drift of an already acquired strain of P. carinii.
Translated title of the contributionIgM response to a human Pneumocystis carinii surface antigen in HIV-infected patients with pulmonary symptoms.
Original languageEnglish
JournalScandinavian Journal of Infectious Diseases
Volume25
Issue number4
Pages (from-to)515-520
Number of pages6
ISSN0036-5548
Publication statusPublished - 1993

Cite this